USA Radioimmunotherapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Radioimmunotherapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Radioimmunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Radioimmunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bayer Healthcare Pharmaceuticals

    • BioSynthema

    • Clarity Pharmaceuticals

    • Curasight

    • Endocyte

    • Immunomedics

    • Molecular Insight Pharmaceuticals

    • Nordic Nanovector

    • PDL Biopharma

    • Philogen

    • RadioMedix

    • Stella Pharma

    • Telix Pharmaceuticals

    By Type:

    • Non Hodgkin Lymphoma (NHL)

    • Follicular Lymphoma

    • Solid Tumors

    • Breast Cancer

    • Ovarian Cancer

    • Osteosarcoma

    • Neuroblastoma

    • Prostate Cancer

    By End-User:

    • Tumor Antigens

    • Radionuclides

    • Antibodies

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Radioimmunotherapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Radioimmunotherapy Market Size and Growth Rate of Non Hodgkin Lymphoma (NHL) from 2016 to 2027

      • 1.3.2 USA Radioimmunotherapy Market Size and Growth Rate of Follicular Lymphoma from 2016 to 2027

      • 1.3.3 USA Radioimmunotherapy Market Size and Growth Rate of Solid Tumors from 2016 to 2027

      • 1.3.4 USA Radioimmunotherapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027

      • 1.3.5 USA Radioimmunotherapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027

      • 1.3.6 USA Radioimmunotherapy Market Size and Growth Rate of Osteosarcoma from 2016 to 2027

      • 1.3.7 USA Radioimmunotherapy Market Size and Growth Rate of Neuroblastoma from 2016 to 2027

      • 1.3.8 USA Radioimmunotherapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Radioimmunotherapy Market Size and Growth Rate of Tumor Antigens from 2016 to 2027

      • 1.4.2 USA Radioimmunotherapy Market Size and Growth Rate of Radionuclides from 2016 to 2027

      • 1.4.3 USA Radioimmunotherapy Market Size and Growth Rate of Antibodies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Radioimmunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Radioimmunotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Non Hodgkin Lymphoma (NHL)

      • 3.4.2 Market Size and Growth Rate of Follicular Lymphoma

      • 3.4.3 Market Size and Growth Rate of Solid Tumors

      • 3.4.4 Market Size and Growth Rate of Breast Cancer

      • 3.4.5 Market Size and Growth Rate of Ovarian Cancer

      • 3.4.6 Market Size and Growth Rate of Osteosarcoma

      • 3.4.7 Market Size and Growth Rate of Neuroblastoma

      • 3.4.8 Market Size and Growth Rate of Prostate Cancer

    4 Segmentation of Radioimmunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Radioimmunotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Radioimmunotherapy in Tumor Antigens

      • 4.4.2 Market Size and Growth Rate of Radioimmunotherapy in Radionuclides

      • 4.4.3 Market Size and Growth Rate of Radioimmunotherapy in Antibodies

    5 Market Analysis by Regions

    • 5.1 USA Radioimmunotherapy Production Analysis by Regions

    • 5.2 USA Radioimmunotherapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Radioimmunotherapy Landscape Analysis

    • 6.1 West USA Radioimmunotherapy Landscape Analysis by Major Types

    • 6.2 West USA Radioimmunotherapy Landscape Analysis by Major End-Users

    7 South USA Radioimmunotherapy Landscape Analysis

    • 7.1 South USA Radioimmunotherapy Landscape Analysis by Major Types

    • 7.2 South USA Radioimmunotherapy Landscape Analysis by Major End-Users

    8 Middle West USA Radioimmunotherapy Landscape Analysis

    • 8.1 Middle West USA Radioimmunotherapy Landscape Analysis by Major Types

    • 8.2 Middle West USA Radioimmunotherapy Landscape Analysis by Major End-Users

    9 Northeast USA Radioimmunotherapy Landscape Analysis

    • 9.1 Northeast USA Radioimmunotherapy Landscape Analysis by Major Types

    • 9.2 Northeast USA Radioimmunotherapy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Bayer Healthcare Pharmaceuticals

        • 10.1.1 Bayer Healthcare Pharmaceuticals Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 BioSynthema

        • 10.2.1 BioSynthema Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Clarity Pharmaceuticals

        • 10.3.1 Clarity Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Curasight

        • 10.4.1 Curasight Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Endocyte

        • 10.5.1 Endocyte Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Immunomedics

        • 10.6.1 Immunomedics Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Molecular Insight Pharmaceuticals

        • 10.7.1 Molecular Insight Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Nordic Nanovector

        • 10.8.1 Nordic Nanovector Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 PDL Biopharma

        • 10.9.1 PDL Biopharma Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Philogen

        • 10.10.1 Philogen Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 RadioMedix

        • 10.11.1 RadioMedix Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Stella Pharma

        • 10.12.1 Stella Pharma Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Telix Pharmaceuticals

        • 10.13.1 Telix Pharmaceuticals Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Non Hodgkin Lymphoma (NHL) from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Follicular Lymphoma from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Solid Tumors from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Ovarian Cancer from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Osteosarcoma from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Neuroblastoma from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Tumor Antigens from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Radionuclides from 2016 to 2027

    • Figure USA Radioimmunotherapy Market Size and Growth Rate of Antibodies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Radioimmunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Radioimmunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Radioimmunotherapy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Radioimmunotherapy by Different Types from 2016 to 2027

    • Table Consumption Share of Radioimmunotherapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Non Hodgkin Lymphoma (NHL)

    • Figure Market Size and Growth Rate of Follicular Lymphoma

    • Figure Market Size and Growth Rate of Solid Tumors

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Ovarian Cancer

    • Figure Market Size and Growth Rate of Osteosarcoma

    • Figure Market Size and Growth Rate of Neuroblastoma

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Radioimmunotherapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Radioimmunotherapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Tumor Antigens

    • Figure Market Size and Growth Rate of Radionuclides

    • Figure Market Size and Growth Rate of Antibodies

    • Table USA Radioimmunotherapy Production by Regions

    • Table USA Radioimmunotherapy Production Share by Regions

    • Figure USA Radioimmunotherapy Production Share by Regions in 2016

    • Figure USA Radioimmunotherapy Production Share by Regions in 2021

    • Figure USA Radioimmunotherapy Production Share by Regions in 2027

    • Table USA Radioimmunotherapy Consumption by Regions

    • Table USA Radioimmunotherapy Consumption Share by Regions

    • Figure USA Radioimmunotherapy Consumption Share by Regions in 2016

    • Figure USA Radioimmunotherapy Consumption Share by Regions in 2021

    • Figure USA Radioimmunotherapy Consumption Share by Regions in 2027

    • Table West USA Radioimmunotherapy Consumption by Types from 2016 to 2027

    • Table West USA Radioimmunotherapy Consumption Share by Types from 2016 to 2027

    • Figure West USA Radioimmunotherapy Consumption Share by Types in 2016

    • Figure West USA Radioimmunotherapy Consumption Share by Types in 2021

    • Figure West USA Radioimmunotherapy Consumption Share by Types in 2027

    • Table West USA Radioimmunotherapy Consumption by End-Users from 2016 to 2027

    • Table West USA Radioimmunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Radioimmunotherapy Consumption Share by End-Users in 2016

    • Figure West USA Radioimmunotherapy Consumption Share by End-Users in 2021

    • Figure West USA Radioimmunotherapy Consumption Share by End-Users in 2027

    • Table South USA Radioimmunotherapy Consumption by Types from 2016 to 2027

    • Table South USA Radioimmunotherapy Consumption Share by Types from 2016 to 2027

    • Figure South USA Radioimmunotherapy Consumption Share by Types in 2016

    • Figure South USA Radioimmunotherapy Consumption Share by Types in 2021

    • Figure South USA Radioimmunotherapy Consumption Share by Types in 2027

    • Table South USA Radioimmunotherapy Consumption by End-Users from 2016 to 2027

    • Table South USA Radioimmunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Radioimmunotherapy Consumption Share by End-Users in 2016

    • Figure South USA Radioimmunotherapy Consumption Share by End-Users in 2021

    • Figure South USA Radioimmunotherapy Consumption Share by End-Users in 2027

    • Table Middle West USA Radioimmunotherapy Consumption by Types from 2016 to 2027

    • Table Middle West USA Radioimmunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Radioimmunotherapy Consumption Share by Types in 2016

    • Figure Middle West USA Radioimmunotherapy Consumption Share by Types in 2021

    • Figure Middle West USA Radioimmunotherapy Consumption Share by Types in 2027

    • Table Middle West USA Radioimmunotherapy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Radioimmunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Radioimmunotherapy Consumption Share by End-Users in 2016

    • Figure Middle West USA Radioimmunotherapy Consumption Share by End-Users in 2021

    • Figure Middle West USA Radioimmunotherapy Consumption Share by End-Users in 2027

    • Table Northeast USA Radioimmunotherapy Consumption by Types from 2016 to 2027

    • Table Northeast USA Radioimmunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Radioimmunotherapy Consumption Share by Types in 2016

    • Figure Northeast USA Radioimmunotherapy Consumption Share by Types in 2021

    • Figure Northeast USA Radioimmunotherapy Consumption Share by Types in 2027

    • Table Northeast USA Radioimmunotherapy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Radioimmunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Radioimmunotherapy Consumption Share by End-Users in 2016

    • Figure Northeast USA Radioimmunotherapy Consumption Share by End-Users in 2021

    • Figure Northeast USA Radioimmunotherapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Bayer Healthcare Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Bayer Healthcare Pharmaceuticals

    • Table Product and Service Introduction of Bayer Healthcare Pharmaceuticals

    • Table Company Profile and Development Status of BioSynthema

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioSynthema

    • Figure Sales and Growth Rate Analysis of BioSynthema

    • Figure Revenue and Market Share Analysis of BioSynthema

    • Table Product and Service Introduction of BioSynthema

    • Table Company Profile and Development Status of Clarity Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Clarity Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Clarity Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Clarity Pharmaceuticals

    • Table Product and Service Introduction of Clarity Pharmaceuticals

    • Table Company Profile and Development Status of Curasight

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curasight

    • Figure Sales and Growth Rate Analysis of Curasight

    • Figure Revenue and Market Share Analysis of Curasight

    • Table Product and Service Introduction of Curasight

    • Table Company Profile and Development Status of Endocyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endocyte

    • Figure Sales and Growth Rate Analysis of Endocyte

    • Figure Revenue and Market Share Analysis of Endocyte

    • Table Product and Service Introduction of Endocyte

    • Table Company Profile and Development Status of Immunomedics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics

    • Figure Sales and Growth Rate Analysis of Immunomedics

    • Figure Revenue and Market Share Analysis of Immunomedics

    • Table Product and Service Introduction of Immunomedics

    • Table Company Profile and Development Status of Molecular Insight Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Molecular Insight Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Molecular Insight Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Molecular Insight Pharmaceuticals

    • Table Product and Service Introduction of Molecular Insight Pharmaceuticals

    • Table Company Profile and Development Status of Nordic Nanovector

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordic Nanovector

    • Figure Sales and Growth Rate Analysis of Nordic Nanovector

    • Figure Revenue and Market Share Analysis of Nordic Nanovector

    • Table Product and Service Introduction of Nordic Nanovector

    • Table Company Profile and Development Status of PDL Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PDL Biopharma

    • Figure Sales and Growth Rate Analysis of PDL Biopharma

    • Figure Revenue and Market Share Analysis of PDL Biopharma

    • Table Product and Service Introduction of PDL Biopharma

    • Table Company Profile and Development Status of Philogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philogen

    • Figure Sales and Growth Rate Analysis of Philogen

    • Figure Revenue and Market Share Analysis of Philogen

    • Table Product and Service Introduction of Philogen

    • Table Company Profile and Development Status of RadioMedix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RadioMedix

    • Figure Sales and Growth Rate Analysis of RadioMedix

    • Figure Revenue and Market Share Analysis of RadioMedix

    • Table Product and Service Introduction of RadioMedix

    • Table Company Profile and Development Status of Stella Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stella Pharma

    • Figure Sales and Growth Rate Analysis of Stella Pharma

    • Figure Revenue and Market Share Analysis of Stella Pharma

    • Table Product and Service Introduction of Stella Pharma

    • Table Company Profile and Development Status of Telix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Telix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Telix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Telix Pharmaceuticals

    • Table Product and Service Introduction of Telix Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.